UGent spin-off Indigo Diabetes concludes a €38 million round of financing

(22-09-2020) Indigo Diabetes nv, announced the conclusion of a €38 million Series B funding round to further develop its promising Multi-Biomarker Sensor for diabetes.

The funding round was led by Fund+, with the participation of Ackermans & van Haaren, imec.xpand, Capricorn Digital Growth Fund, QBICII, Titan Baratto and the Series A investors.

Read more here